HPV Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

HPV Vaccines Market: By Product Type (Bivalent, Polyvalent, Others) By Disease Indication (HPV Associated Cancer, Genital Warts, Others) End User (Hospitals & Retail Pharmacies, Government Suppliers, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

HPV Vaccines Market is expected to be valued at USD 4,867.9 million in 2022 and growing at a CAGR of 5.3% over the forecast period by 2028. Higher demand for an effective vaccine, growing investments in research and development, increase in the number of HPV cases act as the drivers boosting the global market. Few restrain include imposing stringent policies for supplying vaccines and limited availability of medicine. Introduction of novel immunization remedies provide multiple opportunities to the global HPV vaccines market This report studies dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global HPV vaccines market

HPV Vaccines Market

MARKET SUMMARY
-
5.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

HPV Vaccines Market

  • Global HPV vaccines market report gives comprehensive outlook on HPV vaccines market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global HPV vaccines market gives historical, current, and future market sizes on the basis of product type, disease indication, end user and region.
Company Profiles
  • GlaxoSmithKline plc.
  • Merck & Co., Inc
  • Johnson & Johnson
  • Serum Institute of India Pvt. Ltd.
  • Sanofi S.A.
HPV Vaccines Market Drivers

It is noticed that the global HPV vaccines market has a significant market growth rate on perspective of increasing prevalence of cervical cancer. Cervical cancer is a type of cancer that occurs in the cells of the cervix the lower part of the uterus that connects to the vagina. Various strains of the human papillomavirus (HPV), a sexually transmitted infection, play a role in causing most cervical cancer. When exposed to HPV, the body’s immune system typically prevents the virus from doing harm. In a small percentage of people, however, the virus survives for years, contributing to the process that causes some cervical cells to become cancer cells.


North America Got Significant Share

HPV Vaccines Market

North America contributed major revenue followed by Europe and Asia Pacific. In 2021, North America region accounted huge growth rate and is anticipated to grow with a forecast year due to the presence of key market players. Europe hold the second largest on perspective of initiatives taken by the governments. Asia Pacific dominate the global HPV vaccines market with the help of emerging countries like India and the rising relevance of disease

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
HPV Vaccines Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The HPV vaccines market is projected to expand at a CAGR of 5.3% during the forecast period

GlaxoSmithKline plc., Merck & Co., Inc, Johnson & Johnson, Serum Institute of India Pvt. Ltd., Sanofi S.A.

North America is the fastest-growing region for HPV vaccines market


Report

Table Of Content

1. Executive Summary
2. Global HPV Vaccines Market Introduction
2.1. Global HPV Vaccines Market – Taxonomy
2.2. Global HPV Vaccines Market –Definitions
2.2.1. Product Type
2.2.2. Disease Indication
2.2.3. End User
3. Global HPV Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global HPV Vaccines Market Dynamic Factors – Impact Analysis
3.6. Global HPV Vaccines Market – Competition Landscape
4. Global HPV Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global HPV Vaccines Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Bivalent
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Polyvalent
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global HPV Vaccines Market Forecast, By Disease Indication, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1. HPV Associated Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Genital Warts
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global HPV Vaccines Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Hospitals & Retail Pharmacies
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Government Suppliers
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global HPV Vaccines Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global HPV Vaccines Market – Opportunity Analysis Index, By Product Type, Disease Indication, End User and Region, 2022 – 2028
9. North America HPV Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Bivalent
9.1.2. Polyvalent
9.1.3. Others
9.2. Disease Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. HPV Associated Cancer
9.2.2. Genital Warts
9.2.3. Others
9.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals & Retail Pharmacies
9.3.2. Government Suppliers
9.3.3. Others
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America HPV Vaccines Market – Opportunity Analysis Index, By Product Type, Disease Indication, End User and Country, 2022 – 2028
9.6. North America HPV Vaccines Market Dynamics – Trends
10. Europe HPV Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Bivalent
10.1.2. Polyvalent
10.1.3. Others
10.2. Disease Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. HPV Associated Cancer
10.2.2. Genital Warts
10.2.3. Others
10.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals & Retail Pharmacies
10.3.2. Government Suppliers
10.3.3. Others
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe HPV Vaccines Market – Opportunity Analysis Index, By Product Type, Disease Indication, End User and Country, 2022 – 2028
10.6. Europe HPV Vaccines Market Dynamics – Trends
11. Asia-Pacific HPV Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Bivalent
11.1.2. Polyvalent
11.1.3. Others
11.2. Disease Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. HPV Associated Cancer
11.2.2. Genital Warts
11.2.3. Others
11.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals & Retail Pharmacies
11.3.2. Government Suppliers
11.3.3. Others
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific HPV Vaccines Market – Opportunity Analysis Index, By Product Type, Disease Indication, End User and Country, 2022 – 2028
11.6. Asia-Pacific HPV Vaccines Market Dynamics – Trends
12. Latin America HPV Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Bivalent
12.1.2. Polyvalent
12.1.3. Others
12.2. Disease Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. HPV Associated Cancer
12.2.2. Genital Warts
12.2.3. Others
12.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals & Retail Pharmacies
12.3.2. Government Suppliers
12.3.3. Others
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America HPV Vaccines Market – Opportunity Analysis Index, By Product Type, Disease Indication, End User and Country, 2022 – 2028
12.6. Latin America HPV Vaccines Market Dynamics – Trends
13. Middle East and Africa HPV Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Bivalent
13.1.2. Polyvalent
13.1.3. Others
13.2. Disease Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. HPV Associated Cancer
13.2.2. Genital Warts
13.2.3. Others
13.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals & Retail Pharmacies
13.3.2. Government Suppliers
13.3.3. Others
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA HPV Vaccines Market – Opportunity Analysis Index, By Product Type, Disease Indication, End User and Country, 2022 – 2028
13.6. MEA HPV Vaccines Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. GlaxoSmithKline plc.
14.2.2. Merck & Co., Inc
14.2.3. Johnson & Johnson
14.2.4. Serum Institute of India Pvt. Ltd.
14.2.5. Sanofi S.A.
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • GlaxoSmithKline plc.
  • Merck & Co., Inc
  • Johnson & Johnson
  • Serum Institute of India Pvt. Ltd.
  • Sanofi S.A.

Description

HPV Vaccines Market is expected to be valued at USD 4,867.9 million in 2022 and growing at a CAGR of 5.3% over the forecast period by 2028. Higher demand for an effective vaccine, growing investments in research and development, increase in the number of HPV cases act as the drivers boosting the global market. Few restrain include imposing stringent policies for supplying vaccines and limited availability of medicine. Introduction of novel immunization remedies provide multiple opportunities to the global HPV vaccines market This report studies dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global HPV vaccines market

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX